KAVITA GOYAL: Open Payments
NPI 1902109762 · STATE COLLEGE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$860 in 44 payments from 8 companies in 2025. Trend: 2023 $954 · 2024 $253 · 2025 $860
Food & beverage: $860
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 6 | $312 |
| PFIZER INC. | 11 | $151 |
| ABBVIE INC. | 12 | $143 |
| Novo Nordisk Inc | 10 | $140 |
| GlaxoSmithKline, LLC. | 2 | $46 |
| Dexcom, Inc. | 1 | $27 |
| Sumitomo Pharma America, Inc. | 1 | $23 |
| Abbott Laboratories | 1 | $19 |
Products named: ZEPBOUND, NURTEC ODT, QULIPTA, Wegovy, Ozempic, SHINGRIX, UBRELVY, Dexcom G6 Transmitter.
Industry payments across PA — which companies pay providers there.
